Neuphoria Therapeutics Inc 10-K for FY2026
Neuphoria Therapeutics Inc. (NEUP)
10-K
2026-09-18
For: 2026-06-30
View Original
Added on
September 18, 2026
About this 10-K
Neuphoria Therapeutics Inc filed this 10-K on September 18, 2026, covering the fiscal year ended June 30, 2026 (FY2026).
Headline figures
Fiscal year ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.17M
- down 92.5% from $15.65M a year earlier
- Net loss
- $13.45M
- compared with a net loss of $369.63K a year earlier
- Diluted EPS
- -$3.06
- compared with -$0.23 a year earlier